Combined supplementation of vanadium and beta-carotene suppresses placental glutathione S-transferase-positive foci and enhances antioxidant functions during the inhibition of diethylnitrosamine-induced rat liver carcinogenesis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 19, Issue 6, 2004, Pages 683-693

  Chattopadhyay, Mitali Basu ^a   Kumar CB, Mahendra ^a   Kanna, P Suresh ^a   Ray, Rajarshi Sankar ^a   Roy, Souvik ^a   Chatterjee, Malay ^a  

^a JADAVPUR UNIVERSITY   (India)

Author keywords

Beta carotene; Diethylnitrosamine; Glutathione; Glutathione S transferase; Placental glutathione S transferase; Rat hepatocarcinogenesis; Vanadium

Indexed keywords

BETA CAROTENE; DIETHYLNITROSAMINE; GLUTATHIONE TRANSFERASE; VANADIUM;

AEROBIC METABOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHEMOPROPHYLAXIS; CONTROLLED STUDY; CYTOARCHITECTURE; ENZYME ACTIVITY; LIVER CARCINOGENESIS; MALE; NONHUMAN; PARTIAL HEPATECTOMY; PLACENTA; PRIORITY JOURNAL; RAT;

EID: 3042819720     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2004.03378.x     Document Type: Article

References (50)

1. Farber E. The sequential analysis of liver cancer induction. Biochim. Biophys. Acta 1980; 605: 149-66.
2. Elizabeth M, Fauziah O, Asmah R, Maznah I, Asmah Y, Siti M. Changes in morphology of induced liver cancer treated with Strobilanthes crispus. Anal. Microsc. 2000; 1: 23-32.
3. Singer B, Grunberger D. Molecular Biology and Mutagens and Carcinogens. New York, NY: Plenium Press, 1984; 431-50.
4. Cozzi R, Ricordy R, Agilitti T, Gatta V, Perticono P, Desalvia R. Ascorbic acid and beta-carotene as modulators of oxidative damage. Carcinogenesis 1997; 18: 223-8.
5. Boone CW, Kellof GJ, Malone WE. Identification of candidate cancer chemopreventive agents and their evaluation in animal models and human clinical trials: a review. Cancer Res. 1990; 50: 2-9.
6. Bishayee A, Chatterjee M. Inhibition of altered liver cell foci and persistent nodule growth by vanadium during diethylnitrosamine-induced hepatocarcinogenesis in rats. Anticancer Res. 1995a; 15: 455-62.
7. Chakraborty A, Selvaraj S. Differential modulation of xenobiotic metabolizing enzymes by vanadium during DEN-induced hepatocarcinogenesis in Sprague-Dawley rats. Neoplasma 2000; 47: 81-9.
8. Djordjevic C. Antitumor activity of vanadium compounds. Met. Ions Biol. Syst. 1995; 31: 595-616.
9. Sakurai H, Tamura H, Okatawi K. Mechanism for a new antitumor vanadium complex: hydroxyl radical dependent DNA cleavage by 1,10-phenanthroline-vandyl complexes in the presence of hydrogen peroxide. Biochem. Biophys. Res. Commun. 1995; 206: 113-37.
10. Bishayee A, Chatterjee M. Inhibitory effect of vanadium on rat liver carcinogenesis initiated with diethyl nitrosamine and promoted by Phenobarbital. Br. J. Cancer 1995b; 71: 1214-20.
11. Krinsky NJ. Carotenoids and cancer in animal models. J. Nutr. 1989; 119: 123-6.
12. Sarkar A, Mukherjee B, Chatterjee M. Inhibition of 3′-methyl-4- dimethyl-aminobenzene-induced hepatic carcinogenesis in rats by dietary beta-carotene: changes in hepatic antioxidant defense enzyme levels. Int. J. Cancer 1995; 61: 799-805.
13. Moreno FS, Rizzi MBSI, Dagli MLZ, Penteado MVC. Inhibitory effect of beta-carotene on preneoplastic lesions induced in Wister rats by the resistant hepatocyte model. Carcinogenesis 1991; 12: 1817-22.
14. Tsuda H, Uehara N, Iwahori Y et al. Chemopreventive effects of beta-carotene, alpha-tocopherol and five naturally occurring antioxidants on initiation of hepatocarcinogenesis by 2-amino-3-methylimidazo [4,5-f] quiline in the rat. Jpn. J. Cancer Res. 1994; 85: 1214-19.
15. Collins AR. Carotenoids and genomic stability. Mutat. Res. 2001; 475: 21-8.
16. Alpha-tocopherol, β-carotene cancer prevention Study Group. The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers. N. Engl. J. Med. 1994; 330: 1029-35.
17. Omenn GS, Goodman GE, Thornquist MD et al. Effects of a combination of beta-carotene and vitamin A on lung cancer and cardiovascular disease. N. Engl. J. Med. 1996; 334: 1150-5.
18. Collins AR. Carotenoids and genomic stability. Mutat. Res. 2001; 475: 21-8.
19. Bendich A. The safety of beta-carotene. Nutr. Cancer 1988; 11: 207-14.
20. Hennekens CH, Mayrent SL, Willet W. Vitamin A, carotenoids and retinoids. Cancer 1986; 58: 1837-41.
21. Hathcock JN, Hatton DJ, Jenkins MY, McDonald JT, Sunderesan PR, Wilkening VL. Evaluation of vitamin A toxicity. Am. J. Clin. Nutr. 1990; 52: 183-202.
22. Ito N, Tsuda H, Tatematsu M, Hasegawa R, Tsuda H. Medium-term bioassay system for detection of carcinogens and modifiers of hepatocarcinogenesis utilizing the GST-positive liver cells focus as an endpoint marker. Toxicol. Pathol. 1989; 17: 630-41.
23. Hendrich S, Cambell H, Pilot H. Quantitative stereological evaluation of four histochemical markers of altered foci in multistage hepatocarcinogenesis in the rat. Carcinogenesis 1987; 8: 1245-50.
24. Tatamatsu M, Mera Y, Ito N, Satoh K, Sato K. Relative merits of immunohistochemical demonstrations of placental, A, B and C forms of glutathione S transferase and histochemical demonstration of γ-glutamyltransferase as markers of altered foci during liver carcinogenesis in rats. Carcinogenesis 1985; 6: 1621-6.
25. Pilot H. Altered hepatic foci: their role in murine hepatocarcinogenesis. Annu. Rev. Pharmacol. Toxicol. 1990; 30: 465-500.
26. Sato K. Glutathione transferase as markers of preneoplasia and neoplasia. Adv. Cancer Res. 1990; 52: 205-55.
27. Chesseaud LF. The role of glutathione and glutathione S-transferase in the metabolism of chemical carcinogens and other electrophilic agents. Adv. Cancer Res. 1979; 29: 175-274.
28. Wattenberg LW. Inhibition of carcinogenesis by minor dietary constituents. Cancer Res. 1992; 52: 2085-91.
29. Nijhoff WA, Groen GM, Peters WHM. Induction of rat hepatic and intestinal glutathione S-transferase and glutathione by dietary naturally occurring anticarcinogens. Int. J. Oncol. 1993; 3: 1131-9.
30. Bhattacharya S. The genesis, status and future of environmental toxicology. Indian J. Exp. Biol. 1996; 34: 1131-5.
31. Sarkar A, Basak R, Bishayee A, Basak J, Chatterjee M. β-carotene inhibits rat liver chromosomal aberrations and DNA chain break after a single injection of diethylnitrosmine. Br. J. Cancer 1997; 76: 855-61.
32. Bannasch P. Cytology and cytogenetics of neoplastic (hyperplastic) hepatic nodules. Cancer Res. 1976; 36: 2555-62.
33. Stewart HL, Williams GM, Keysser CH, Lombard LS, Montait RJ. Histological typing of liver tumors of the rat. J. Natl Cancer Inst. 1980; 64: 117-207.
34. Ellman GE. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 1959; 82: 70-7.
35. Habig WH, Pabst MJ, Jacoby WB. Glutathione S-transferase, the first enzymatic step in mercapturic acid formation. J. Biol. Chem. 1974; 249: 7130-9.
36. Lowry OH, Rosebrough NJ, Farr AL, Randall RL. Protein measurement with the folin phenol reagent. J. Biol. Chem. 1951; 193: 265-75.
37. Kaku T, Ekem J, Lindayen C, Bailey D, van Nostrand A, Farber E. Comparison of formalin and acetone fixation for immunohistochemical detection of carcinoembryonic antigen (CEA) and keratin. Am. J. Clin. Pathol 1983; 80: 806-15.
38. Bondi A, Chieregatti G, Eusebi U, Fulcheri E, Bussolati G. The use of β-galactosidase stain as a tracer in immunocytochemistry. Histochemistry 1982; 76: 153-8.
39. Warburg OA. On the origin of cancer cells. Science 1956; 123: 309-15.
40. Boik JC. Cancer and Natural Medicine: a Textbook of Basic Science Research and Clinical Research. Oregon: Oregon Medical Press, 1996.
41. Satoh K, Kitahara A, Soma Y, Inaba Y, Hatayama I, Sato K. Purification, induction and distribution of placental glutathione transferase: a new marker enzyme for preneoplastic cells in the rat chemical hepatocarcinogenesis. Proc. Natl Acad. Sci. 1985; 82: 3964-8.
42. Moreno FS, Ton SW, Naves MMV et al. Inhibitory effects of beta-carotene and vitamin A during the progression phase of hepatocarcinogenesis involve of cell proliferation but not alterations in DNA methylation. Nutr. Cancer 2002; 44: 80-9.
43. Uhlig S, Wendel A. The physiological consequences of glutathione variations. Life Sci. 1992; 51: 1083-94.
44. Kulkarni AA, Kulkarni AP. Retionoids inhibit mammalian glutathione transferase. Cancer Lett. 1995; 91: 335-84.
45. Mannervik B, Danielson UH. Glutathione transferases - structure and catalytic activity. CRC Crit. Rev. Biochem. 1988; 23: 283-7.
46. Chatterjee M, Bishayee A. Vanadium - a new tool in cancer chemoprevention: Recent progress and future opportunities. In: Nriagu JO, ed. Vanadium in the Environment. Part 2: Health Effects. New York: John Wiley, 1998; 347-89.
47. Krinsky NI. Effects of carotenoids on cellular and animal systems. Am. J. Clin. Nutr. 1991; 53: 238-46S.
48. Krinsky NI. Micronutrients and their influence on mutagenicity and malignant transformation. Ann. NY Acad. Sci. 1993; 686: 229-42.
49. He RK, Gascon-Barré M. Influence of the Vitamin D status on the early hepatic response to carcinogen exposure in rats. J. Pharmacol Exp. Ther. 1997; 281: 464-9.
50. Muto Y, Fuji J, Moriwaki H, Kawaguchi T, Noda T. Growth retardation in human cervical dysplasia-derived cell lines by beta-carotene through down-regulation of epidermal growth factor receptor. Am. J. Clin. Nutr. 1995; 62: 1535-40S.